Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMUNOR for Prevention of COVID-19 in Healthcare Professionals
NCT04710381Phase 4Completed
- Sponsor
- University Hospital Ostrava
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Imunor in coronavirus disease 2019 (COVID-19), sponsored by University Hospital Ostrava. Started Feb 2021; status: completed.
02
Drugs
Imunor
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04710381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04710381.